OA12175A - Pharmaceutical composition for intramuscular injection containing loxoprofen. - Google Patents

Pharmaceutical composition for intramuscular injection containing loxoprofen. Download PDF

Info

Publication number
OA12175A
OA12175A OA1200200244A OA1200200244A OA12175A OA 12175 A OA12175 A OA 12175A OA 1200200244 A OA1200200244 A OA 1200200244A OA 1200200244 A OA1200200244 A OA 1200200244A OA 12175 A OA12175 A OA 12175A
Authority
OA
OAPI
Prior art keywords
sodium
loxoprofen
injection
composition according
intramuscular injection
Prior art date
Application number
OA1200200244A
Other languages
English (en)
Inventor
Shin Han
Hye-Seon Kim
Sung-Tae Lee
Chul-Kyu Lee
Woo-Yle Park
Original Assignee
Shin Poong Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Poong Pharmaceutical Co filed Critical Shin Poong Pharmaceutical Co
Publication of OA12175A publication Critical patent/OA12175A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA1200200244A 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen. OA12175A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0076298A KR100405161B1 (ko) 2000-12-14 2000-12-14 록소프로펜 함유 근육주사제 조성물

Publications (1)

Publication Number Publication Date
OA12175A true OA12175A (en) 2006-05-09

Family

ID=36691545

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200244A OA12175A (en) 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen.

Country Status (12)

Country Link
JP (1) JP2004515526A (es)
KR (1) KR100405161B1 (es)
CN (1) CN1278672C (es)
AP (1) AP1530A (es)
AR (1) AR033596A1 (es)
AU (1) AU2002222750A1 (es)
BR (1) BR0108313A (es)
MX (1) MXPA02007788A (es)
OA (1) OA12175A (es)
RU (1) RU2232572C2 (es)
UA (1) UA76097C2 (es)
WO (1) WO2002047661A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
HRP20150037T4 (hr) 2003-04-08 2022-09-02 Progenics Pharmaceuticals, Inc. Farmaceutske formulacije koje sadrže metilnaltrekson
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
US8227430B2 (en) 2007-09-04 2012-07-24 Meiji Seika Pharma Co., Ltd Injectable, injection solution, and injection kit preparation
EP2243477A1 (de) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
JP2011225514A (ja) * 2009-10-30 2011-11-10 Kowa Co ロキソプロフェン又はその塩含有の医薬組成物
EP2926810A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen
EP2926832A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of loxoprofen for topical use
WO2015165847A1 (en) 2014-04-29 2015-11-05 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulations of loxoprofen
EP3160507A1 (en) 2014-06-30 2017-05-03 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and gamma-aminobutiric acid receptor agonist combinations
WO2016046189A1 (en) 2014-09-24 2016-03-31 Sanovel Ilac Sanayi Ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161538A (en) * 1977-04-05 1979-07-17 Sankyo Company Limited Substituted phenylacetic acid derivatives and process for the preparation thereof
JPH0747535B2 (ja) * 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
JPH10120560A (ja) * 1996-08-26 1998-05-12 Sankyo Co Ltd ロキソプロフェン含有外用製剤
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy

Also Published As

Publication number Publication date
KR100405161B1 (ko) 2003-11-12
AU2002222750A1 (en) 2002-06-24
JP2004515526A (ja) 2004-05-27
UA76097C2 (en) 2006-07-17
BR0108313A (pt) 2003-03-11
AP1530A (en) 2006-01-04
AP2002002594A0 (en) 2002-09-30
KR20020046407A (ko) 2002-06-21
WO2002047661A1 (en) 2002-06-20
CN1278672C (zh) 2006-10-11
MXPA02007788A (es) 2002-10-17
CN1400892A (zh) 2003-03-05
AR033596A1 (es) 2003-12-26
RU2232572C2 (ru) 2004-07-20

Similar Documents

Publication Publication Date Title
EP0490689B1 (en) 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1)
CA2234140C (fr) Formulation pharmaceutique lyophilisee stable
KR100372966B1 (ko) 경구투여용액체알렌드로네이트제형
US5674885A (en) Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes
KR20010013712A (ko) 수용성 케토프로펜 염을 함유하는 약학적 제제 및 그의 용도
MXPA04004024A (es) Composicion farmaceutica de acido 2-(4-isobutilfenil) propionico.
WO2002047661A1 (en) Pharmaceutical composition for intramuscular injection containing loxoprofen
HU199293B (en) Process for production of tepically applicable medical compositions suitable for treatment of peptical ulcus by mammates
WO2007022165A2 (en) Factor xa inhibitor inclusion complex with cyclodextrin
EP0393909A1 (en) Composition
MXPA01006698A (es) Solucion de las al monosodica de la n-[o-(p-pivaloiloxibencensulfonilamino)benzoil]glilicina tetrahidratada y producto farmaceutico de la misma.
US4645768A (en) Formulations
EP0551180B1 (en) Use of bucillamine for the manufacture of a medicament for the treatment of cystinuria
CA2055661A1 (en) Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
JP2025504136A (ja) イソキサゾリン誘導体を含む注射用製剤及びこの製造方法
ES2215025T3 (es) Formulacion farmaceutica efervescente, que contiene metamizol.
JPH0696527B2 (ja) 消炎鎮痛ゲル剤
TWI301413B (en) Pharmaceutical composition for intramuscular injection containing loxoprofen
ES2280846T3 (es) Formulacion oromucosal y procedimiento para su preparacion.
WO2023281449A1 (en) Method of production of the composition of cyclooxygenase-2 (cox-2) inhibitors
HK40105417A (zh) 环氧合酶-2(cox-2)抑制剂组合物的制造方法
JPH10152439A (ja) フマル酸ケトチフェン含有医薬組成物
TW200403989A (en) Methods and compositions for treatment of cancer pain
MXPA01007003A (es) Nuevo uso del melagatran
HU189796B (en) Process for production of watery medical solution consisting of l-3,4-dihidroxi-phenil-alpha-methil-alinin